147 related articles for article (PubMed ID: 29045018)
1. Patient, disease, and treatment factors associated with overall survival in esthesioneuroblastoma.
Carey RM; Godovchik J; Workman AD; Kuan EC; Parasher AK; Chen J; Palmer JN; Adappa ND; Newman JG; Brant JA
Int Forum Allergy Rhinol; 2017 Dec; 7(12):1186-1194. PubMed ID: 29045018
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Open and Endoscopic Approaches in the Resection of Esthesioneuroblastoma.
Barinsky GL; Azmy MC; Kilic S; Grube JG; Baredes S; Hsueh WD; Eloy JA
Ann Otol Rhinol Laryngol; 2021 Feb; 130(2):136-141. PubMed ID: 32627574
[TBL] [Abstract][Full Text] [Related]
3. Esthesioneuroblastoma: A Patterns-of-Care and Outcomes Analysis of the National Cancer Database.
Orton A; Boothe D; Evans D; Lloyd S; Monroe MM; Jensen R; Shrieve DC; Hitchcock YJ
Neurosurgery; 2018 Nov; 83(5):940-947. PubMed ID: 29481629
[TBL] [Abstract][Full Text] [Related]
4. Combined modality therapy of esthesioneuroblastoma.
McLean JN; Nunley SR; Klass C; Moore C; Müller S; Johnstone PA
Otolaryngol Head Neck Surg; 2007 Jun; 136(6):998-1002. PubMed ID: 17547995
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of Kadish staging in esthesioneuroblastoma: An analysis of the National Cancer Database.
Konuthula N; Iloreta AM; Miles B; Rhome R; Ozbek U; Genden EM; Posner M; Misiukiewicz K; Govindaraj S; Shrivastava R; Gupta V; Bakst RL
Head Neck; 2017 Oct; 39(10):1962-1968. PubMed ID: 28815831
[TBL] [Abstract][Full Text] [Related]
6. [A retrospective study about 11 cases of Esthesioneuroblastomas treated in Hospital Santa Creu i Sant Pau between 2000 and 2008 and literature review].
Muñoz F; Tresserras P; Montserrat JR; Sancho FJ; Bartumeus F
Neurocirugia (Astur); 2011 Oct; 22(5):401-17; discussion 417-8. PubMed ID: 22031159
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes of patients with esthesioneuroblastomas: A cohort from a single institution.
Yin ZZ; Gao L; Luo JW; Yi JL; Huang XD; Qu Y; Wang K; Zhang SP; Xiao JP; Xu GZ; Li YX
Oral Oncol; 2016 Feb; 53():48-53. PubMed ID: 26712253
[TBL] [Abstract][Full Text] [Related]
8. Multimodality therapy including radiotherapy and chemotherapy improves event-free survival in stage C esthesioneuroblastoma.
Eich HT; Hero B; Staar S; Micke O; Seegenschmiedt H; Mattke A; Berthold F; Müller RP
Strahlenther Onkol; 2003 Apr; 179(4):233-40. PubMed ID: 12707712
[TBL] [Abstract][Full Text] [Related]
9. Esthesioneuroblastoma in childhood and adolescence. Better prognosis with multimodal treatment?
Eich HT; Müller RP; Micke O; Kocher M; Berthold F; Hero B
Strahlenther Onkol; 2005 Jun; 181(6):378-84. PubMed ID: 15925980
[TBL] [Abstract][Full Text] [Related]
10. Multimodality Treatment of Pediatric Esthesioneuroblastoma.
Venkatramani R; Pan H; Furman WL; Marron JM; Haduong J; Friedrich-Medina P; Mahajan A; Bavle A; Wu H; Chintagumpala M
Pediatr Blood Cancer; 2016 Mar; 63(3):465-70. PubMed ID: 26514449
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic factors and outcome of esthesioneuroblastoma].
Zhao LJ; Gao L; Xu GZ; Li SY; Xiao GL
Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):561-4. PubMed ID: 16438858
[TBL] [Abstract][Full Text] [Related]
12. [Primary experience and discussion on the treatment of esthesioneuroblastoma].
Jiang LJ; Lin TJ; Huang ZQ; Zuo KJ; Zhang Y; Shi JB; Lai YY
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Jul; 56(7):719-723. PubMed ID: 34344098
[No Abstract] [Full Text] [Related]
13. Comparing Kadish, TNM, and the modified Dulguerov staging systems for esthesioneuroblastoma.
Joshi RR; Husain Q; Roman BR; Cracchiolo J; Yu Y; Tsai J; Kang J; McBride S; Lee NY; Morris L; Ganly I; Tabar V; Cohen MA
J Surg Oncol; 2019 Jan; 119(1):130-142. PubMed ID: 30466166
[TBL] [Abstract][Full Text] [Related]
14. Endoscopic endonasal resection of esthesioneuroblastoma: A single center experience of 24 patients.
Feng L; Fang J; Zhang L; Li H; Zhou B; Chen X; Li Y; Han D
Clin Neurol Neurosurg; 2015 Nov; 138():94-8. PubMed ID: 26310690
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy in Esthesioneuroblastoma/Olfactory Neuroblastoma: An Analysis of the Surveillance Epidemiology and End Results (SEER) 1973-2015 Database.
Cranmer LD; Chau B; Rockhill JK; Ferreira M; Liao JJ
Am J Clin Oncol; 2020 Mar; 43(3):203-209. PubMed ID: 31842117
[TBL] [Abstract][Full Text] [Related]
16. Nasal and paranasal esthesioneuroblastomas: clinical outcomes.
Michel J; Fakhry N; Santini L; Mancini J; Giovanni A; Dessi P
Eur Ann Otorhinolaryngol Head Neck Dis; 2012 Oct; 129(5):238-43. PubMed ID: 22341153
[TBL] [Abstract][Full Text] [Related]
17. Multidisciplinary treatment of olfactory neuroblastoma: Patterns of failure and management of recurrence.
Petruzzelli GJ; Howell JB; Pederson A; Origitano TC; Byrne RW; Munoz L; Emami B; Clark JI
Am J Otolaryngol; 2015; 36(4):547-53. PubMed ID: 25749259
[TBL] [Abstract][Full Text] [Related]
18. Treatment of esthesioneuroblastomas.
König MS; Osnes T; Meling TR
Neurochirurgie; 2014 Aug; 60(4):151-7. PubMed ID: 24975203
[TBL] [Abstract][Full Text] [Related]
19. Multimodal treatment and long-term outcome of patients with esthesioneuroblastoma.
Modesto A; Blanchard P; Tao YG; Rives M; Janot F; Serrano E; Benlyazid A; Guigay J; Ferrand FR; Delord JP; Bourhis J; Daly-Schveitzer N
Oral Oncol; 2013 Aug; 49(8):830-4. PubMed ID: 23747132
[TBL] [Abstract][Full Text] [Related]
20. [Long-term experiences in the therapy of esthesioneuroblastoma].
Koch M; Constantinidis J; Dimmler A; Strauss C; Iro H
Laryngorhinootologie; 2006 Oct; 85(10):723-30. PubMed ID: 16673299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
